Simultaneous Application of Lidocaine and Ketamine During Ambulatory Infusion Therapy: A Retrospective Analysis

References

• Breivik H , EisenbergE , O’BrienT. The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate care. BMC Public Health13, 1229 (2013).
   PubMed Web of Science ®Google Scholar
• Kress L , UceylerN. Pain prevention: what is in the pipeline?Schmerz35(1), 53–58 (2021).
   PubMed Web of Science ®Google Scholar
• Vardeh D , MannionRJ , WoolfCJ. Toward a mechanism-based approach to pain diagnosis. J. Pain17(Suppl. 9), T50–T69 (2016).
   PubMed Web of Science ®Google Scholar
• Mao J . Challenges of managing chronic pain. BMJ356, j741 (2017).
   PubMedGoogle Scholar
• Lovejoy TI , MorascoBJ , DemidenkoMI , MeathTHA , FrankJW , DobschaSK. Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders. Pain158(3), 526–534 (2017).
   PubMed Web of Science ®Google Scholar
• Ballantyne JC , MaoJ. Opioid therapy for chronic pain. N. Engl. J. Med.349(20), 1943–1953 (2003).
   PubMed Web of Science ®Google Scholar
• Mills SEE , NicolsonKP , SmithBH. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br. J. Anaesth.123(2), e273–e283 (2019).
   PubMed Web of Science ®Google Scholar
• Patel AS , FarquharsonR , CarrollDet al. The impact and burden of chronic pain in the workplace: a qualitative systematic review. Pain Pract.12(7), 578–589 (2012).
   PubMed Web of Science ®Google Scholar
• Duenas M , OjedaB , SalazarA , MicoJA , FaildeI. A review of chronic pain impact on patients, their social environment and the health care system. J. Pain Res.9, 457–467 (2016).
   PubMed Web of Science ®Google Scholar
• Paz MGD , SouzaLAF , TatagibaBet al. Factors associated with quality of life of older adults with chronic pain. Rev. Bras. Enferm.74(Suppl. 2), e20200554 (2021).
   PubMedGoogle Scholar
• Steenstra IA , MunhallC , IrvinEet al. Systematic review of prognostic factors for return to work in workers with sub acute and chronic low back pain. J. Occup. Rehabil.27(3), 369–381 (2017).
   PubMed Web of Science ®Google Scholar
• Melcarne L , Garcia-IglesiasP , CalvetX. Management of NSAID-associated peptic ulcer disease. Expert Rev. Gastroenterol. Hepatol.10(6), 723–733 (2016).
   PubMed Web of Science ®Google Scholar
• Freo U , RuoccoC , ValerioA , ScagnolI , NisoliE. Paracetamol: a review of guideline recommendations. J. Clin. Med.10(15), 3420 (2021).
   PubMed Web of Science ®Google Scholar
• Andrade S , BartelsDB , LangeR , SandfordL , GurwitzJ. Safety of metamizole: a systematic review of the literature. J. Clin. Pharm. Ther.41(5), 459–477 (2016).
   PubMed Web of Science ®Google Scholar
• Braund TA , TillmanG , PalmerDM , GordonE , RushAJ , HarrisAWF. Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report. Transl. Psychiatry11(1), 417 (2021).
   PubMed Web of Science ®Google Scholar
• Quintero GC . Review about gabapentin misuse, interactions, contraindications and side effects. J. Exp. Pharmacol.9, 13–21 (2017).
   PubMedGoogle Scholar
• Lee M , SilvermanSM , HansenH , PatelVB , ManchikantiL. A comprehensive review of opioid-induced hyperalgesia. Pain Physician14(2), 145–161 (2011).
   PubMed Web of Science ®Google Scholar
• Hauser W , MorlionB , VowlesKEet al. European* clinical practice recommendations on opioids for chronic noncancer pain – part 1: role of opioids in the management of chronic noncancer pain. Eur. J. Pain25(5), 949–968 (2021).
   PubMed Web of Science ®Google Scholar
• Compton WM , VolkowND. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend.83(Suppl. 1), S4–S7 (2006).
   PubMed Web of Science ®Google Scholar
• Compton WM , VolkowND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend.81(2), 103–107 (2006).
   PubMed Web of Science ®Google Scholar
• Williams DR , StarkRJ. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia23(10), 963–971 (2003).
   PubMed Web of Science ®Google Scholar
• Viola V , NewnhamHH , SimpsonRW. Treatment of intractable painful diabetic neuropathy with intravenous lignocaine. J. Diabetes Complications20(1), 34–39 (2006).
   PubMed Web of Science ®Google Scholar
• Kastrup J , PetersenP , DejgardA , AngeloHR , HilstedJ. Intravenous lidocaine infusion – a new treatment of chronic painful diabetic neuropathy?Pain28(1), 69–75 (1987).
   PubMed Web of Science ®Google Scholar
• Grigoras A , LeeP , SattarF , ShortenG. Perioperative intravenous lidocaine decreases the incidence of persistent pain after breast surgery. Clin. J. Pain28(7), 567–572 (2012).
   PubMed Web of Science ®Google Scholar
• Eichenberger U , NeffF , SveticicGet al. Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds. Anesth. Analg.106(4), 1265–1273, (2008).
   PubMed Web of Science ®Google Scholar
• Schwartzman RJ , AlexanderGM , GrothusenJR , PaylorT , ReichenbergerE , PerreaultM. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. Pain147(1–3), 107–115 (2009).
   PubMed Web of Science ®Google Scholar
• Kandil E , MelikmanE , AdinoffB. Lidocaine infusion: a promising therapeutic approach for chronic pain. J. Anesth. Clin. Res.8(1), 697 (2017).
   PubMedGoogle Scholar
• Calatayud J , GonzalezA. History of the development and evolution of local anesthesia since the coca leaf. Anesthesiology98(6), 1503–1508 (2003).
   PubMed Web of Science ®Google Scholar
• Le Dare B , PelletierR , MorelI , GicquelT. History of ketamine: an ancient molecule that is still popular today. Ann. Pharm. Fr.80(1), 1–8 (2022).
   PubMed Web of Science ®Google Scholar
• Zarate CA Jr , NiciuMJ. Ketamine for depression: evidence, challenges and promise. World Psychiatry14(3), 348–350 (2015).
   PubMed Web of Science ®Google Scholar
• Lener MS , KadriuB , ZarateCAJr. Ketamine and beyond: investigations into the potential of glutamatergic agents to treat depression. Drugs77(4), 381–401 (2017).
   PubMed Web of Science ®Google Scholar
• Niesters M , MartiniC , DahanA. Ketamine for chronic pain: risks and benefits. Br. J. Clin. Pharmacol.77(2), 357–367 (2014).
   PubMed Web of Science ®Google Scholar
• Mayhew A , ArgaezC. Intravenous Lidocaine for Chronic Pain: A Review of the Clinical Effectiveness and Guidelines. Canadian Agency for Drugs and Technologies in Health (2018).
   Google Scholar
• Daradka M , IsmailZB. Evaluation of the clinical and analgesic effects of subarachnoid ketamine–lidocaine administration in goats undergoing mastectomy. Vet. Med. (Auckl.)5, 35–39 (2014).
   PubMedGoogle Scholar
• Kaka U , SaifullahB , AbubakarAAet al. Serum concentration of ketamine and antinociceptive effects of ketamine and ketamine–lidocaine infusions in conscious dogs. BMC Vet. Res.12(1), 198 (2016).
   PubMedGoogle Scholar
• Safakish R , BabazadehS, Emadi T, SohanpaI. Ambulatory infusions of lidocaine and ketamine for management of chronic pain: an observational prospective cohort study. J. Anesth. Pain Res.5, 138 (2022).
   Google Scholar
• Abdallah CG , AdamsTG , KelmendiB , EsterlisI , SanacoraG , KrystalJH. Ketamine’s mechanism of action: a path to rapid-acting antidepressants. Depress. Anxiety33(8), 689–697 (2016).
   PubMed Web of Science ®Google Scholar
• Mion G , VillevieilleT. Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci. Ther.19(6), 370–380 (2013).
   PubMed Web of Science ®Google Scholar
• Cohen SP , BhatiaA , BuvanendranAet al. Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg. Anesth. Pain Med.43(5), 521–546 (2018).
   PubMed Web of Science ®Google Scholar
• Peltoniemi MA , HagelbergNM , OlkkolaKT , SaariTI. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin. Pharmacokinet.55(9), 1059–1077 (2016).
   PubMed Web of Science ®Google Scholar
• Sleigh J HM , VossL , DennyB. Ketamine - more mechanisms of action than just NMDA blockade. Trends in Anaesthesia and Critical Care4(2-3), (2014).
   Google Scholar
• Graven-Nielsen T , KendallSA , HenrikssonKGet al. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain85(3), 483–491 (2000).
   PubMed Web of Science ®Google Scholar
• Kim YH , LeePB , OhTK. Is magnesium sulfate effective for pain in chronic postherpetic neuralgia patients comparing with ketamine infusion therapy?J. Clin. Anesth.27(4), 296–300 (2015).
   PubMed Web of Science ®Google Scholar
• Webster LR , WalkerMJ. Safety and efficacy of prolonged outpatient ketamine infusions for neuropathic pain. Am. J. Ther.13(4), 300–305 (2006).
   PubMedGoogle Scholar
• Lu W , WangL , WoC , YaoJ. Ketamine attenuates osteoarthritis of the knee via modulation of inflammatory responses in a rabbit model. Mol. Med. Rep.13(6), 5013–5020 (2016).
   PubMed Web of Science ®Google Scholar
• Dale O , SomogyiAA , LiY , SullivanT , ShavitY. Does intraoperative ketamine attenuate inflammatory reactivity following surgery? A systematic review and meta-analysis. Anesth. Analg.115(4), 934–943 (2012).
   PubMed Web of Science ®Google Scholar
• Lauretti GR . Mechanisms of analgesia of intravenous lidocaine. Rev. Bras. Anestesiol.58(3), 280–286 (2008).
   PubMedGoogle Scholar
• Estebe JP . Intravenous lidocaine. Best Pract. Res. Clin. Anaesthesiol.31(4), 513–521 (2017).
   PubMedGoogle Scholar
• Yang X , WeiX , MuY , LiQ , LiuJ. A review of the mechanism of the central analgesic effect of lidocaine. Medicine (Baltimore)99(17), e19898 (2020).
   PubMed Web of Science ®Google Scholar
• Muth-Selbach U , HermannsH , StegmannJUet al. Antinociceptive effects of systemic lidocaine: involvement of the spinal glycinergic system. Eur. J. Pharmacol.613(1–3), 68–73 (2009).
   PubMed Web of Science ®Google Scholar
• Sugimoto M , UchidaI , MashimoT. Local anaesthetics have different mechanisms and sites of action at the recombinant N-methyl-D-aspartate (NMDA) receptors. Br. J. Pharmacol.138(5), 876–882 (2003).
   PubMed Web of Science ®Google Scholar
• Kurabe M , FurueH , KohnoT. Intravenous administration of lidocaine directly acts on spinal dorsal horn and produces analgesic effect: an in vivo patch-clamp analysis. Sci. Rep.6, 26253 (2016).
   PubMed Web of Science ®Google Scholar
• Dunn LK , DurieuxME. Perioperative use of intravenous lidocaine. Anesthesiology126(4), 729–737 (2017).
   PubMed Web of Science ®Google Scholar
• Kvarnstrom A , KarlstenR , QuidingH , GordhT. The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury. Acta Anaesthesiol. Scand.48(4), 498–506 (2004).
   PubMed Web of Science ®Google Scholar
• Jendoubi A , NaceurIB , BouzouitaAet al. A comparison between intravenous lidocaine and ketamine on acute and chronic pain after open nephrectomy: A prospective, double-blind, randomized, placebo-controlled study. Saudi J. Anaesth.11, 177–84 (2017).
   PubMed Web of Science ®Google Scholar
• Fillingim RB , DoleysDM , EdwardsRR , LoweryD. Clinical characteristics of chronic back pain as a function of gender and oral opioid use. Spine (Phila. Pa 1976)28(2), 143–150 (2003).
   PubMed Web of Science ®Google Scholar
• Tang YR , YangWW , WangYL , LinL. Sex differences in the symptoms and psychological factors that influence quality of life in patients with irritable bowel syndrome. Eur. J. Gastroenterol. Hepatol.24(6), 702–707 (2012).
   PubMed Web of Science ®Google Scholar
• Niesters M , DahanA , KestBet al. Do sex differences exist in opioid analgesia? A systematic review and meta-analysis of human experimental and clinical studies. Pain151(1), 61–68 (2010).
   PubMed Web of Science ®Google Scholar
• Bartley EJ , FillingimRB. Sex differences in pain: a brief review of clinical and experimental findings. Br. J. Anaesth.111(1), 52–58 (2013).
   PubMed Web of Science ®Google Scholar
• Quinlan J . The use of a subanesthetic infusion of intravenous ketamine to allow withdrawal of medically prescribed opioids in people with chronic pain, opioid tolerance and hyperalgesia: outcome at 6 months. Pain Med.13(11), 1524–1525 (2012).
   PubMed Web of Science ®Google Scholar